Robin Wagner has worked in the environmental health and injury fields for over 25 years in government, university and non-profit settings. She spent 12 years at the U.S. Centers for Disease Control and Prevention (CDC) where she oversaw the development of CDC's first agency-wide research agenda and research portfolio assessment program. In 2008, she joined the U.S. National Institutes of Health as the Director of the Division of Statistical Analysis and Reporting in the Office of Extramural Research, Office of the Director. In September 2014, she returned to the CDC as the Chief Science Officer of the Office of Public Health Scientific Services. Dr. Wagner has a Ph.D. in Epidemiology from the Johns Hopkins Bloomberg School of Public Health, a M.S. in Technology and Policy from the Massachusetts Institute of Technology, and a Sc.B. in Neuroscience and Behavior from Brown University.
Dr. Joshua Schnell is a Director at Clarivate Analytics, formerly the IP & Science business of Thomson Reuters. He has expertise in science planning and assessment, the evaluation of research and development (R&D) programs, and in science and technology (S&T) policy, and helps to set the strategic direction of Clarivate solutions. Previously, he oversaw a team of analysts conducting program evaluations of research and training programs and developing tools for data-driven science management. Before joining Clarivate Analytics, Dr. Schnell directed the analytics group at a science management start-up in the Washington DC area, worked in research administration at Northwestern University, and was an S&T Policy Graduate Fellow at the US National Academies of Science. He holds a PhD from Northwestern University.
Dr. Alexandra Stone is an evaluation task manager at Ripple Effect. Her work focuses on the quantitative analysis of research outcomes and impacts and network analysis of research communities. She has also evaluated the impacts of several NIH STEM training programs for high school and college students. Prior to joining Ripple Effect, Dr. Stone worked at the Government Accountability Office, Science and Technology Policy Institute, and the Institute for Defense Analysis. Over the course of her career, Dr. Stone has contributed to program evaluations and policy analyses for the NIH, Department of Defense, Department of Labor, NSF, Government Accountability Office, and White House Office of Science and Technology Policy. Dr. Stone has received awards for her research from the World Intellectual Property Organization, Association of University Technology Managers, and NSF. She earned a Ph.D. in Public Policy from the University of Texas at Austin and a Master of Science from Georgetown University.
Dr. Danielle Daee is a program director in the National Cancer Institute's (NCI) Division of Cancer Control and Population Sciences where she manages a portfolio of grants related to genetic factors modulating susceptibility to cancer. Dr. Daee also leads the assessment and evaluation of several ongoing initiatives in the program. Formerly, Dr. Daee was a Health Science Analyst in NCI's Office of Science Planning and Assessment where she worked on evaluation and analysis activities across NCI. Prior to joining the NCI in 2012, she earned a Ph.D. in cancer biology from the University of Nebraska Medical Center in 2006 and completed a post-doctoral fellowship at the National Human Genome Research Institute in 2012. Danielle has served as the RTD TIG Webmaster since 2013.
TIG Leader Emeritus
Dr. Gretchen Jordan is an independent consultant specializing in a systems view of innovation and program and evaluation design that considers the full range of research, development, and market adoption initiatives and the logical connections among them. Until December 2011 she was a Principal Member of the Technical Staff with Sandia National Laboratories working with the U.S. Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy, and the DOE Office of Science, on evaluation and performance measurement and innovative methods of assessing the effectiveness of research organizations. She was the North American Editor of Research Evaluation from 2008 to 2015, is a Fellow of the American Association for the Advancement of Science, and co-founder (in 1995) and leader emeritus of the American Evaluation Association's Topical Interest Group on Research, Technology, and Development Evaluation. She has a Ph.D. in Economics. Prior to joining Sandia in 1991, Gretchen was Chairman of the Business Administration Department at the College of Santa Fe and staff member of U.S. Senator Pete V. Domenici and the Senate Budget Committee.
Dr. Brian Zuckerman brings expertise in the areas of program evaluation and scientometrics. His work at STPI focuses on Federal research and development program performance and agency-wide research portfolios, with an emphasis on biomedical research. Zuckerman has also analyzed Federal research and development data systems and statistical data collection programs. Before joining STPI, he was a principal at C-STPS, LLC, and at the Center for Science and Technology Policy of Abt Associates Inc. He is a co-chair of the Research, Technology, and Development Topical Interest Group of the American Evaluation Association. Zuckerman holds a BA in chemistry from Harvard College and a PhD in Technology, Management, and Policy from the Massachusetts Institute of Technology.